Bellicum Pharmaceuticals Reports First Quarter 2019 Financial Results and Provides Operational Update

by in

Interim data for BPX-601 accepted for presentation at upcoming American Society of
Clinical Oncology (ASCO) Annual Meeting

Rivo-cel™ on-track for topline data readout from BP-004 pediatric trial in second quarter of 2019